Psychedelics Today is the planetary leader in psychedelic education, media, and advocacy. Covering up-to-the-minute developments and diving deep into crucial topics bridging the scientific, academic, philosophical, societal, and cultural, Psychedelics Today is leading the discussion in this rapidly evolving ecosystem.
In this episode, Joe interviews 4-time guest Dena Justice, who is using this episode to come out of the psychedelic closet in a big way, discussing the lessons learned about safety from years of powerful psychedelic experiences.
In today’s Solidarity Fridays episode, Kyle, Joe, and Michelle discuss Carl Hart, the drug war and truth, another study showcasing the placebo effect, mushrooms, and if scientists will be able to predict psychedelic outcomes.
In this episode, Joe and Kyle interview author of Drug Use for Grownups, Dr. Carl Hart. They talk about the drug war, coming out of the closet, drug exceptionalism, responsible drug use, and fighting inaccuracies with logic.
In today’s Solidarity Fridays episode, Kyle, Joe, and Michelle discuss the problems with psychedelics being touted as “miracle cures,” and Tim Ferriss and David Bronner's concerns over Compass Pathways' recent patent-filing.
In this episode, Joe interviews Leo Russell, Monique Bridges, Malika Lamont, Tatiana, and Solana Booth of the Entheo Society of Washington, a 501c3 organization and sister agency to Decriminalize Nature Seattle.
In today’s Solidarity Fridays episode, Kyle, Joe, and Michelle are joined by Balázs Szigeti and David Erritzoe, who both worked on last week’s much-discussed trial on microdosing that validated the power of the placebo effect.
In this episode, Kyle interviews somatic salvia guide and creator of the salvia pipe, Christopher Solomon. They talk about the many unique things salvia can bring to experiencers if it's approached with mindfulness and respect.
In today’s Solidarity Fridays episode, Kyle, Joe, and Michelle discuss using MDMA for alcoholism, a microdosing study proving the placebo effect, ways to make therapy cheaper, and if a Shaman is really necessary for ceremonies.
In this episode, Joe interviews founder and CEO of MindMed, JR Rahn. They discuss decriminalization, the DEA, ADHD, Xanax, and MindMed’s goals: developing a trip-neutralizing drug and studying microdosing LSD for adult ADHD.